Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
370M
-
Number of holders
-
132
-
Total 13F shares, excl. options
-
60.3M
-
Shares change
-
+3.18M
-
Total reported value, excl. options
-
$85.7M
-
Value change
-
+$4.91M
-
Put/Call ratio
-
0.23
-
Number of buys
-
52
-
Number of sells
-
-48
-
Price
-
$1.42
Significant Holders of PRECIGEN, INC. - Common Stock (PGEN) as of Q3 2023
148 filings reported holding PGEN - PRECIGEN, INC. - Common Stock as of Q3 2023.
PRECIGEN, INC. - Common Stock (PGEN) has 132 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 60.3M shares
of 370M outstanding shares and own 16.3% of the company stock.
Largest 10 shareholders include Patient Capital Management, LLC (13.8M shares), BlackRock Inc. (10.5M shares), VANGUARD GROUP INC (6.95M shares), GEODE CAPITAL MANAGEMENT, LLC (2.91M shares), STATE STREET CORP (2.77M shares), IRIDIAN ASSET MANAGEMENT LLC/CT (2.08M shares), MILLENNIUM MANAGEMENT LLC (1.42M shares), JPMORGAN CHASE & CO (1.34M shares), RENAISSANCE TECHNOLOGIES LLC (1.32M shares), and NORTHERN TRUST CORP (1.09M shares).
This table shows the top 132 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.